Corrigendum to ‘Interferon Α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation’ [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947]
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2019.03.007
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elsevier BV